Literature DB >> 11839231

Development and implementation of an inpatient acute palliative care service.

Philip H Santa-Emma1, Ralph Roach, Mary Ann Gill, Pam Spayde, Robert M Taylor.   

Abstract

CONTEXT: Although hospice programs are a well-established feature of the American medical system, inpatient palliative care services are a recent development. Therefore limited data about inpatient palliative care services has been published, and no large series has yet been reported.
OBJECTIVE: To describe the development and implementation, as well as the characteristics and effectiveness, of a large inpatient acute palliative care service (APCS). DESIGN, SETTING, AND PARTICIPANTS: Data on patient demographics, diagnoses, key symptoms, and outcome were collected on each of the 3,712 patients seen from March 1997 to December 2000 by the APCS in a midwestern urban-suburban three-hospital system. Summary statistics were calculated and analyzed. MAIN OUTCOME MEASURES: APCS intervention, most common symptoms, and diagnoses, survival, and discharge destination.
RESULTS: Of the 3,712 patients seen by the APCS, 56.9% were transferred to the acute palliative care units (APCU) from elsewhere in the hospital, 16.3% were directly admitted to the APCU, and 26.9% were seen in consultation by the APCS without transfer to the APCU. The most common symptoms were dyspnea (53.9%), weakness (42.5%), and pain (40.8%); 88.7% of patients had one to three symptoms. The most frequent diagnoses were cancer (41.3%), cardiac disease (17.4%), pulmonary disease (14.0%), and stroke (9.4%). Of all patients seen by the APCS, 49.5% survived to discharge, although patients whose primary diagnosis was cancer or dementia had significantly higher discharge rates (64.7% and 59.6% respectively, p < 0.001). Of those discharged, 72.0% went home or to an extended care (ECF) with hospice, 13.8% went to an facility ECF without hospice, and 14.2% went home with other home care services.
CONCLUSION: Mount Carmel Health has developed an APCS and APCU integrated into the mainstream of each of its hospitals, providing an opportunity for a more appropriate focus on end-of-life issues for patients with poor prognoses, intense medical needs, and complex family issues.

Entities:  

Mesh:

Year:  2002        PMID: 11839231     DOI: 10.1089/10966210252785051

Source DB:  PubMed          Journal:  J Palliat Med        ISSN: 1557-7740            Impact factor:   2.947


  6 in total

1.  Discharge outcomes and survival of patients with advanced cancer admitted to an acute palliative care unit at a comprehensive cancer center.

Authors:  David Hui; Ahmed Elsayem; Shana Palla; Maxine De La Cruz; Zhijun Li; Sriram Yennurajalingam; Eduardo Bruera
Journal:  J Palliat Med       Date:  2010-01       Impact factor: 2.947

2.  Palliative care consultations in hospitalized stroke patients.

Authors:  Robert G Holloway; Susan Ladwig; Jessica Robb; Adam Kelly; Eric Nielsen; Timothy E Quill
Journal:  J Palliat Med       Date:  2010-04       Impact factor: 2.947

3.  Palliative care consultation service and palliative care unit: why do we need both?

Authors:  Jan Gaertner; Sebastian Frechen; Markus Sladek; Christoph Ostgathe; Raymond Voltz
Journal:  Oncologist       Date:  2012-02-21

4.  Potential Influence of Advance Care Planning and Palliative Care Consultation on ICU Costs for Patients With Chronic and Serious Illness.

Authors:  Nita Khandelwal; David C Benkeser; Norma B Coe; J Randall Curtis
Journal:  Crit Care Med       Date:  2016-08       Impact factor: 7.598

5.  Opioid use and effectiveness of its prescription at discharge in an acute pain relief and palliative care unit.

Authors:  Sebastiano Mercadante; Giovanna Prestia; Maurizio Ranieri; Antonello Giarratano; Alessandra Casuccio
Journal:  Support Care Cancer       Date:  2013-02-12       Impact factor: 3.603

6.  Dysphagia as a predictor of outcome and transition to palliative care among middle cerebral artery ischemic stroke patients.

Authors:  Christa O'Hana V San Luis; Ilene Staff; Gilbert J Fortunato; Louise D McCullough
Journal:  BMC Palliat Care       Date:  2013-05-10       Impact factor: 3.234

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.